发明名称 Clear ophthalmic solution comprising latanoprost as active ingredient
摘要 A clear ophthalmic solution containing latanoprost having a concentration of 0.005% (W/V), 0.003 to 0.01% (W/V) benzalkonium chloride and at least one agent selected from the group consisting of glycerin, polyethylene glycol, propylene glycol and trehalose, wherein the agent is in a concentration to make the solution isotonic. A method of preventing white turbidity in an ophthalmic solution containing latanoprost having a concentration of 0.005% (W/V) and 0.003 to 0.01% (W/V) benzalkonium chloride, the method involving adding to the solution at least one agent selected from the group consisting of glycerin, polyethylene glycol, propylene glycol and trehalose, wherein the agent is in a concentration to make the solution isotonic.
申请公布号 US8183291(B2) 申请公布日期 2012.05.22
申请号 US20100807045 申请日期 2010.08.26
申请人 ASADA HIROYUKI;KIMURA AKIO;SANTEN PHARMACEUTICAL CO., LTD. 发明人 ASADA HIROYUKI;KIMURA AKIO
分类号 A61K31/19;A61K9/00;A61K31/5575;A61K47/10;A61K47/18;A61K47/26;A61K47/44;A61P27/06 主分类号 A61K31/19
代理机构 代理人
主权项
地址